Laboratoire Riva Inc. Ranitidine Product Recall (2019-10-24)

Starting date:
October 24, 2019
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-71421

Last updated:
  1. Acid Reducer 75mg
  2. Riva-Ranitidine 150mg
  3. Riva-Ranitidine 300mg

Reason

Affected lots may be manufactured with an API containing an impurity, N-nitrosodimethylamine (NDMA)

Depth of distribution

Wholesalers, Healthcare Establishments, Retailers

Affected products

A. Acid Reducer 75mg

DIN, NPN, DIN-HIM

DIN 02452464

Dosage form

Tablet

Strength

Ranitidine hydrochloride 75mg

Lot or serial number

All lots

Companies

Recalling Firm
Laboratoire Riva Inc.
660 Industriel Boulevard
Blainville
J7C 3V4
Quebec
CANADA
Marketing Authorization Holder
Laboratoire Riva Inc.
660 Industriel Boulevard
Blainville
J7C 3V4
Quebec
CANADA

B. Riva-Ranitidine 150mg

DIN, NPN, DIN-HIM

DIN 02247814

Dosage form

Tablet

Strength

Ranitidine hydrochloride 150mg

Lot or serial number

All lots

Companies

Recalling Firm
Laboratoire Riva Inc.
660 Industriel Boulevard
Blainville
J7C 3V4
Quebec
CANADA
Marketing Authorization Holder
Laboratoire Riva Inc.
660 Industriel Boulevard
Blainville
J7C 3V4
Quebec
CANADA

C. Riva-Ranitidine 300mg

DIN, NPN, DIN-HIM

DIN 02247815

Dosage form

Tablet

Strength

Ranitidine hydrochloride 300mg

Lot or serial number

All lots

Companies

Recalling Firm
Laboratoire Riva Inc.
660 Industriel Boulevard
Blainville
J7C 3V4
Quebec
CANADA
Marketing Authorization Holder
Laboratoire Riva Inc.
660 Industriel Boulevard
Blainville
J7C 3V4
Quebec
CANADA